AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday

AEON Biopharma (NASDAQ:AEON) is expected to be posting its quarterly earnings results before the market opens on Tuesday, May 13th. Analysts expect AEON Biopharma to post earnings of ($13.67) per share for the quarter.

AEON Biopharma Stock Up 3.4 %

Shares of AEON stock opened at $0.47 on Friday. AEON Biopharma has a 12-month low of $0.38 and a 12-month high of $269.28. The firm has a market capitalization of $4.99 million, a price-to-earnings ratio of 2.63 and a beta of 0.38. The firm has a fifty day moving average of $0.54 and a 200-day moving average of $20.49.

About AEON Biopharma

AEON Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder.